Lidocaine injection recalled due to glass particulate matter
Pfizer Inc. is recalling 21,390 vials of Lidocaine Hydrochloride 1% injection due to presence of glass particulate matter. Lot 42290DK with expiration 6/1/2024 is affected.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification for an injectable drug with identified glass particulate contamination meets the threshold for Severe severity. Although no illnesses or injuries have been reported in the source text, the concrete identification of a foreign particulate hazard in an intravenous injection presents serious risk of harm.
Plain-English summary
Pfizer Inc. is recalling 21,390 vials of Lidocaine Hydrochloride 1% Injection, USP (50mg/5mL), distributed as single-use glass syringes. The recalled product is lot number 42290DK with an expiration date of 6/1/2024.
The recall is initiated due to the presence of glass particulate matter identified in the product. This intravenous anesthetic injection was distributed nationwide throughout the United States and Puerto Rico, but was not distributed to government accounts or foreign consignees.
Healthcare providers and patients currently using this product should discontinue use immediately and consult with their healthcare provider. The affected lot can be identified by lot number 42290DK on the vial label.
This FDA Class I recall indicates a potentially serious health hazard. Persons experiencing adverse events related to this product should report them to the FDA's MedWatch program or contact Pfizer Inc. directly.
The recalled product
- Product
- LIDOCAINE HYDROCHLORIDE (LIDOCAINE HYDROCHLORIDE)
- Brand
- LIDOCAINE HYDROCHLORIDE
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Injectable
- Hazard
- glass-particulate-matter
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 42290DK
- Exp. 6/1/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LIDOCAINE HYDROCHLORIDE
- HighLidocaine Hydrochloride Injection Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-04-22
- HighLidocaine Hydrochloride Injection Recalled Nationwide for Sterility Assurance Issues
FDA (Drugs) · 2026-04-22
- SeverePfizer Lidocaine Injection Recall: Glass Particulates in Injectable Medication
FDA (Drugs) · 2023-11-15
- SevereLidocaine Hydrochloride Topical Solution recalled for being superpotent
FDA (Drugs) · 2022-01-05
- ModerateLidocaine Hydrochloride Topical Solution Recalled for Superpotency
FDA (Drugs) · 2022-01-05
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27